Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Class B Common Stock
-
Shares outstanding
-
5.07M
-
Number of holders
-
384
-
Total 13F shares, excl. options
-
19.5M
-
Shares change
-
+264K
-
Total reported value, excl. options
-
$5.46B
-
Value change
-
+$100M
-
Put/Call ratio
-
0.55
-
Number of buys
-
176
-
Number of sells
-
-185
-
Price
-
$280.39
Significant Holders of BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) as of Q3 2025
438 filings reported holding BIO - BIO-RAD LABORATORIES, INC. - Class B Common Stock as of Q3 2025.
BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) has 384 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 19.5M shares
.
Largest 10 shareholders include First Eagle Investment Management, LLC (2.52M shares), VANGUARD GROUP INC (1.79M shares), BlackRock, Inc. (1.7M shares), DIMENSIONAL FUND ADVISORS LP (1.06M shares), Veritas Asset Management LLP (844K shares), ARIEL INVESTMENTS, LLC (809K shares), EARNEST PARTNERS LLC (609K shares), STATE STREET CORP (572K shares), BANK OF AMERICA CORP /DE/ (460K shares), and Capital Research Global Investors (418K shares).
This table shows the top 384 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.